Alfonso Quintas Cardama's Net Worth
-$38.2 Thousand
Who is Alfonso Quintas Cardama?
Alfonso Quintas Cardama does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TCR2 THERAPEUTICS INC., and Foghorn Therapeutics Inc..
SEC CIK
Alfonso Quintas Cardama's CIK is 0001760104
Past Insider Trading and Trends
2022 was Alfonso Quintas Cardama's most active year for acquiring shares with 12 total transactions. Alfonso Quintas Cardama's most active month to acquire stocks was the month of November. 2022 was Alfonso Quintas Cardama's most active year for disposing of shares, totalling 14 transactions. Alfonso Quintas Cardama's most active month to dispose stocks was the month of May. 2023 saw Alfonso Quintas Cardama paying a total of $2,059,040.00 for 272,000 shares, this is the most they've acquired in one year. In 2022 Alfonso Quintas Cardama cashed out on 417,243 shares for a total of $40,347.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TCR2 THERAPEUTICS INC. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -109.46K |
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| -11.20% | -13.80K |
$1.10 | -$15,122.82 | 109.46K |
Scheduled
|
Dec 9 - Dec 13
| ||
Form 4
| -6.05% | -7.94K |
$1.27 | -$10,081.21 | 123.26K |
Scheduled
|
Dec 7 - Dec 8
| ||
Form 4
| -5.38% | -7.46K |
$1.35 | -$10,089.67 | 131.2K |
Scheduled
|
Dec 5 - Dec 6
| ||
Form 4
| +195.56% | 91.75K |
$1.39 | -$5,054.04 | 138.66K |
Scheduled
|
Dec 1 - Dec 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
| +1,150.73% | 43.16K |
$0.79 | $34,158.64 | 46.91K |
Aug 31 - Dec 9
| |||
Form 4
| +94.86% | 1.83K |
$12.43 | $22,705.71 | 3.75K |
Aug 31 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
∞
| 1.93K |
$11.26 | $21,676.45 | 1.93K |
Aug 30 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foghorn Therapeutics Inc. (FHTX) Snapshot price: $3.13
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||